Matina Liapi | Karolinska Institutet

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: IMMUNO-ONCOLOGY AND TECHNOLOGY. 2024;22:100713
Effect of glucocorticoids for the management of immune-related adverse events on outcome in melanoma patients treated with immunotherapy-a retrospective and biomarker study.
Costa Svedman F; Liapi M; Månsson-Broberg A; Chatzidionysiou K; Egyhazi Brage S
Article: RHEUMATOLOGY. 2021;60(10):4616-4623
Venous thromboembolism in ANCA-associated vasculitis: a population-based cohort study.
Liapi M; Jayne D; Merkel PA; Segelmark M; Mohammad AJ

Alla övriga publikationer

Meeting abstract: ANNALS OF ONCOLOGY. 2023;34:s688-s689
Association of immune-related adverse events (irAE) requiring glucocorticoids (GCs) with outcome and biomarkers in advanced cutaneous malignant melanoma (CMM) treated with immune checkpoint inhibitors (ICI)
Svedman FC; Liapi M; Chatzidionysiou A; Mansson-Broberg A; Brage SE
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:2053-2054
RISK FACTORS FOR DEVELOPING RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS AFTER IMMUNOTHERAPY WITH IMMUNE CHECKPOINT INHIBITORS
Liapi M; Chatzidionysiou K
Review: CLINICAL RHEUMATOLOGY. 2021;40(5):1687-1695
Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift?
Chatzidionysiou K; Liapi M; Tsakonas G; Gunnarsson I; Catrina A

Nyheter från KI

Kalenderhändelser från KI